Muscle oxidative capacity during IL-6-dependent cancer cachexia.
about
The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established ConceptsMechanisms of metabolic dysfunction in cancer-associated cachexiaEffects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and diseaseQuercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.Cachectic skeletal muscle response to a novel bout of low-frequency stimulationInhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunctionSildenafil increases muscle protein synthesis and reduces muscle fatigue.The effect of radiation dose on mouse skeletal muscle remodeling.The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexiaInterleukin 6 as a key regulator of muscle mass during cachexiaLiver inflammation and metabolic signaling in ApcMin/+ mice: the role of cachexia progression.Sex differences in the relationship of IL-6 signaling to cancer cachexia progressionPreserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia.The effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse.Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases.IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.Eccentric contraction-induced myofiber growth in tumor-bearing mice.Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexiaMolecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingPseudouridine synthase 1 deficient mice, a model for Mitochondrial Myopathy with Sideroblastic Anemia, exhibit muscle morphology and physiology alterations.TWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity.Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia.Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia.Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia.Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse.Are there any benefits of exercise training in cancer cachexia?Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency.Effect of colon cancer and surgical resection on skeletal muscle mitochondrial enzyme activity in colon cancer patients: a pilot study.Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle.Skeletal Muscle Function During the Progression of Cancer Cachexia in the Male ApcMin/+ Mouse.Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Autophagy activation, not peroxisome proliferator-activated receptor γ coactivator 1α, may mediate exercise-induced improvements in glucose handling during diet-induced obesity.
P2860
Q28078802-03164838-487E-4027-A04D-EDE24237D99AQ28079213-A0DBFC32-FC3C-4599-B73E-CA03C29B04E5Q28606560-1AF9CC03-C51B-4FAC-A08E-911C937D8D02Q33602156-3FC38B44-CDFB-4F39-B45B-CC2AD7A6D782Q33673314-6CF17E25-13A7-46F6-B910-EB86B3A6F2A8Q33775184-25C7DAA6-8673-4845-B9C6-579C326E5449Q33827719-93137176-6931-4372-AF89-7F2889AFEB65Q33946332-9665D349-3C04-46AA-935A-04074DB5F521Q34031423-50306645-396B-41E4-9EB2-29F5C1F69C7FQ34200939-79CC7EF9-44F3-4FFE-AEB8-6970CB1C046CQ34727530-A3CE3517-BF67-44AB-8E3C-08F139DC3954Q35196068-334B4671-D7E9-4947-8D4B-F3905187FEC9Q35214154-C18188CE-9A84-45C2-B1D0-C6F07CAAF8A9Q35690207-BF97CB16-04ED-43E2-9CB4-85D17FDF25EDQ36028206-92D531F7-FAC4-4231-B1D8-748DFA5D9D5FQ36082495-5560213A-526C-40B9-8CD2-6E203E168D80Q36200582-3464658C-C304-461C-8616-BBF21AC3ACBEQ36422662-CC7CF6B8-F161-4FC8-A377-6C401C0E7076Q36487406-56D506ED-E092-4BC5-917B-9D52CF7DC98CQ36737744-FA7F7FF8-128E-4CC9-AFFB-57C2D8B39B6CQ36787452-A2D355D8-8369-4B51-B4A7-370098613445Q36901945-9362DCC8-DADF-4E6A-8271-00F62E254A15Q36919088-2433D87C-EE4F-4FB0-9667-E0D3DC590A0EQ37014194-7B2C4F4E-CF5C-47E5-B9FE-CE7CEE62D0F1Q37392800-95AA8930-78AD-44EF-8CCA-469FB06646B2Q37407291-8CF4524A-E2FA-4854-B196-75E70640BBC2Q37644886-22A032EF-7629-431F-A44E-550EDC46C4BAQ37924325-E8BD6F54-3F34-448A-9817-4B6BE2195AB7Q38090981-1F6590AA-84FB-4167-A8B6-E21D452F6C72Q38606110-F7ECCBB5-7934-46F0-AD4C-C6471F5F20DCQ39292567-C30DE1F3-B626-464F-B93F-D36B51D70B29Q41146515-07A1E721-F3E5-4B5E-8A7B-173463136C3CQ41293262-19DAA3D7-9380-4A50-B0BF-EDB987C34D6DQ42199742-F0D846EB-0A8E-45ED-8BCA-5EA667159D74Q42350705-7AC5A289-A746-40AB-8732-4E170796D991Q43240375-D647308D-B41B-4C84-945B-B4AE2308B5CEQ47320394-39F0D80B-59F5-48DB-AAC2-D5A4A578EA91Q47419257-930A1A6E-91E9-49BB-AB5D-CE168F55DF7FQ48155681-36ED50D8-9151-4D48-A441-4C17233F1323Q48238486-FDBE7FEA-3DB0-4A61-A588-8C51DFC6D59A
P2860
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@ast
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@en
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@nl
type
label
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@ast
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@en
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@nl
prefLabel
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@ast
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@en
Muscle oxidative capacity during IL-6-dependent cancer cachexia.
@nl
P2093
P2860
P1476
Muscle oxidative capacity during IL-6-dependent cancer cachexia
@en
P2093
James P White
John W Baynes
Kristen A Baltgalvis
Melissa J Puppa
Shuichi Sato
P2860
P304
P356
10.1152/AJPREGU.00300.2010
P577
2010-12-09T00:00:00Z